PharmaCyte Biotech, Inc. - PMCB

SEC FilingsOur PMCB Tweets

About Gravity Analytica

Recent News

  • 03.18.2026 - 4 - Statement of changes in beneficial ownership of securities
  • 03.18.2026 - SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  • 03.17.2026 - 10-Q - Quarterly report [Sections 13 or 15(d)]
  • 03.09.2026 - ARS - Annual Report to Security Holders
  • 03.09.2026 - DEF 14A - Definitive proxy statements
  • 02.27.2026 - PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition
  • 02.13.2026 - SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors
  • 01.27.2026 - CORRESP - Correspondence
  • 01.27.2026 - UPLOAD - SEC-generated letter
  • 01.07.2026 - 4 - Statement of changes in beneficial ownership of securities

Recent Filings

  • 03.09.2026 - DEF 14A Other definitive proxy statements
  • 03.09.2026 - ARS Annual Report to Security Holders
  • 02.27.2026 - PRE 14A Other preliminary proxy statements
  • 02.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
  • 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
  • 12.18.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]